期刊文献+

特发性血小板减少性紫癜患者血小板生成素和幽门螺杆菌检测的临床意义

Clinical Significance of Thrombopoietin and Helicobacter Pylori in Patients with Idiopathic Thrombocytopenic Purpura
下载PDF
导出
摘要 目的探讨特发性血小板减少性紫癜(ITP)患者血小板生成素(TPO)和幽门螺杆菌(HP)检测的临床意义。方法60例初治ITP患者,在接收治疗前采用双抗体夹心酶联免疫吸附法(ELISA)检测血清TPO水平,计数骨髓涂片的平均巨核细胞数量,用14C尿素呼气试验检测患者HP感染情况。结果对治疗反应无效的ITP患者,其TPO水平明显高于治疗有效者及对照组(P<0.05),后两者间无显著差异(P>0.05);巨核细胞计数无效者显著低于有效者(P<0.01);60例ITP患者共检出HP感染30例,与对照组(17例)无显著性差异(P>0.05),但是在13例治疗无效的ITP患者中HP阳性占10例,明显高于对照组(P<0.05),进行抗HP治疗后血小板(PLT)明显升高者6例。结论ITP患者中,血清高水平TPO、骨髓低巨核细胞计数可能预示治疗困难;对常规治疗无效者,HP可能参与其发病,部分抗HP治疗有效。 Objective To investigate the clinical significance of thrombopoietin(TPO) and Helicobacter pylori(HP) in patients with idiopathic thrombocytopenic purpura(ITP).Methods 60 patients with newly diagnosed ITP,their serum TPO concentration were detected by double-antibody sandwich enzyme-linked immunosorbent assay(ELISA);and the bone Marrow megakaryocytes were recorded;HP was detected by 14^C urea breath test.The control group of 40 cases was also detected by above methods.Results the TPO of ineffective group with ITP were significantly higher than that of the effective group and the control group(P〈0.05);The megakaryocytes of ineffective group were significantly lower than that of the effective group(P〈0.01).HP was found in 30 of 60 patients,17 was found of 40 in the control group(P〉0.05).But HP was found in 10 of 13 patients of ineffective group,that was significantly higher than control group(P〈0.05),the platelet counts of 6 significantly increased in 10 patients after anti-HP treatment.Conclusion High levels of serum TPO and lower megakaryocyte counts may indicate that the treatment of ITP is more difficult;HP may be involved in its pathogenesis,anti-HP treatment is effective in part of ITP.
出处 《湖北民族学院学报(医学版)》 2008年第3期41-43,共3页 Journal of Hubei Minzu University(Medical Edition)
关键词 特发性血小板减少性紫癜 血小板生成素 幽门螺杆菌 Idiopathic thrombocytopenic purpura Thrombopoietin Helicobacter pylori
  • 相关文献

参考文献8

  • 1Tahara T, Usuki K, Sara H, et al. A sensitive sandwich EIASA for measuring thrombopoietin in human sermn TPO levels in healthy volunteers and in patients with hae- mopoietic disorders [ J ]. Br J Haematol, 1996,93 ( 4 ) : 783 - 788.
  • 2Kaushansky K. Throbopoietin:The primary regulator of platelet production [ J ]. Blood, 1995,86 (2) :419 - 426.
  • 3Sakane Y, Wada H, Kazuyo H, et al. Increased thrombopoietin levels in idiopathic thrombocytopenic purpura patients with a poor response to setriod therapy [ J ]. Blood coagul Fibrinolysis, 1998,9 (4) :315 - 321.
  • 4肖燕,林雯,刘勤,蒙冰,金润铭,费洪宝.血小板生成素和巨核细胞对特发性血小板减少性紫癜患儿预后的影响[J].实用儿科临床杂志,2006,21(15):987-988. 被引量:5
  • 5Gasbarrini A, Fracechi F, Tartaglione R, et al. Regression of autoimmune thrombocytopenia after eradication of Helicobacter pylori [ J ]. Lancet, 1998,352 (9131 ) : 878.
  • 6Kohda K, Kuga T, Kogawa K, et al. Effect of helicobacter pylori eradication on platelet recovery in Japanese patients with chronic idiopathic thrombocytopenic purpura and secondary autoimmune thrombocytopenic purpura [ J ]. Br J Haematol,2002 ,118 :584.
  • 7Cooper N, Bussel J. The pathogenesis of immune thrombocytopaenic purpura [ J ]. Br J Haematol, 2006,133 (4) : 364 - 374.
  • 8范磊,阮长耿.特发性血小板减少性紫癜发病机制[J].江苏医药,2006,32(4):357-359. 被引量:22

二级参考文献20

共引文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部